Sang-Ging Ong1,2,3, Bruno C Huber1,2,4, Won Hee Lee1,2, Kazuki Kodo1,2, Antje D Ebert1,2, Yu Ma1,2, Patricia K Nguyen1,2, Sebastian Diecke1,2, Wen-Yi Chen1,2, Joseph C Wu1,2,3. 1. Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA. 2. Depts of Medicine and Radiology, Stanford University School of Medicine, Stanford, CA. 3. Institute of Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA. 4. Ludwig-Maximilians-University, Medical Department I, Campus Grosshadern, Munich, Germany.
Abstract
BACKGROUND: Human induced pluripotent stem cells (iPSCs) are attractive candidates for therapeutic use, with the potential to replace deficient cells and to improve functional recovery in injury or disease settings. Here, we test the hypothesis that human iPSC-derived cardiomyocytes (iPSC-CMs) can secrete cytokines as a molecular basis to attenuate adverse cardiac remodeling after myocardial infarction. METHODS AND RESULTS: Human iPSCs were generated from skin fibroblasts and differentiated in vitro with a small molecule-based protocol. Troponin(+) iPSC-CMs were confirmed by immunohistochemistry, quantitative polymerase chain reaction, fluorescence-activated cell sorting, and electrophysiological measurements. Afterward, 2×10(6) iPSC-CMs derived from a cell line transduced with a vector expressing firefly luciferase and green fluorescent protein were transplanted into adult NOD/SCID mice with acute left anterior descending artery ligation. Control animals received PBS injection. Bioluminescence imaging showed limited engraftment on transplantation into ischemic myocardium. However, magnetic resonance imaging of animals transplanted with iPSC-CMs showed significant functional improvement and attenuated cardiac remodeling compared with PBS-treated control animals. To understand the underlying molecular mechanism, microfluidic single-cell profiling of harvested iPSC-CMs, laser capture microdissection of host myocardium, and in vitro ischemia stimulation were used to demonstrate that the iPSC-CMs could release significant levels of proangiogenic and antiapoptotic factors in the ischemic microenvironment. CONCLUSIONS: Transplantation of human iPSC-CMs into an acute mouse myocardial infarction model can improve left ventricular function and attenuate cardiac remodeling. Because of limited engraftment, most of the effects are possibly explained by paracrine activity of these cells.
BACKGROUND:Human induced pluripotent stem cells (iPSCs) are attractive candidates for therapeutic use, with the potential to replace deficient cells and to improve functional recovery in injury or disease settings. Here, we test the hypothesis that human iPSC-derived cardiomyocytes (iPSC-CMs) can secrete cytokines as a molecular basis to attenuate adverse cardiac remodeling after myocardial infarction. METHODS AND RESULTS:Human iPSCs were generated from skin fibroblasts and differentiated in vitro with a small molecule-based protocol. Troponin(+) iPSC-CMs were confirmed by immunohistochemistry, quantitative polymerase chain reaction, fluorescence-activated cell sorting, and electrophysiological measurements. Afterward, 2×10(6) iPSC-CMs derived from a cell line transduced with a vector expressing firefly luciferase and green fluorescent protein were transplanted into adult NOD/SCIDmice with acute left anterior descending artery ligation. Control animals received PBS injection. Bioluminescence imaging showed limited engraftment on transplantation into ischemic myocardium. However, magnetic resonance imaging of animals transplanted with iPSC-CMs showed significant functional improvement and attenuated cardiac remodeling compared with PBS-treated control animals. To understand the underlying molecular mechanism, microfluidic single-cell profiling of harvested iPSC-CMs, laser capture microdissection of host myocardium, and in vitro ischemia stimulation were used to demonstrate that the iPSC-CMs could release significant levels of proangiogenic and antiapoptotic factors in the ischemic microenvironment. CONCLUSIONS: Transplantation of human iPSC-CMs into an acute mousemyocardial infarction model can improve left ventricular function and attenuate cardiac remodeling. Because of limited engraftment, most of the effects are possibly explained by paracrine activity of these cells.
Authors: Ahmad Y Sheikh; Bruno C Huber; Kazim H Narsinh; Joshua M Spin; Koen van der Bogt; Patricia E de Almeida; Katherine J Ransohoff; Daniel L Kraft; Giovanni Fajardo; Diego Ardigo; Julia Ransohoff; Daniel Bernstein; Michael P Fischbein; Robert C Robbins; Joseph C Wu Journal: Arterioscler Thromb Vasc Biol Date: 2011-10-27 Impact factor: 8.311
Authors: Mei Huang; Patricia Nguyen; Fangjun Jia; Shijun Hu; Yongquan Gong; Patricia E de Almeida; Li Wang; Divya Nag; Mark A Kay; Amato J Giaccia; Robert C Robbins; Joseph C Wu Journal: Circulation Date: 2011-09-13 Impact factor: 29.690
Authors: Nicolas Noiseux; Massimiliano Gnecchi; Marco Lopez-Ilasaca; Lunan Zhang; Scott D Solomon; Arjun Deb; Victor J Dzau; Richard E Pratt Journal: Mol Ther Date: 2006-09-11 Impact factor: 11.454
Authors: Roberto Bolli; Atul R Chugh; Domenico D'Amario; John H Loughran; Marcus F Stoddard; Sohail Ikram; Garth M Beache; Stephen G Wagner; Annarosa Leri; Toru Hosoda; Fumihiro Sanada; Julius B Elmore; Polina Goichberg; Donato Cappetta; Naresh K Solankhi; Ibrahim Fahsah; D Gregg Rokosh; Mark S Slaughter; Jan Kajstura; Piero Anversa Journal: Lancet Date: 2011-11-14 Impact factor: 79.321
Authors: Massimiliano Gnecchi; Huamei He; Nicolas Noiseux; Olin D Liang; Lunan Zhang; Fulvio Morello; Hui Mu; Luis G Melo; Richard E Pratt; Joanne S Ingwall; Victor J Dzau Journal: FASEB J Date: 2006-04 Impact factor: 5.191
Authors: Michael A Laflamme; Kent Y Chen; Anna V Naumova; Veronica Muskheli; James A Fugate; Sarah K Dupras; Hans Reinecke; Chunhui Xu; Mohammad Hassanipour; Shailaja Police; Chris O'Sullivan; Lila Collins; Yinhong Chen; Elina Minami; Edward A Gill; Shuichi Ueno; Chun Yuan; Joseph Gold; Charles E Murry Journal: Nat Biotechnol Date: 2007-08-26 Impact factor: 54.908
Authors: Ashley H Fong; Mónica Romero-López; Christopher M Heylman; Mark Keating; David Tran; Agua Sobrino; Anh Q Tran; Hiep H Pham; Cristhian Fimbres; Paul D Gershon; Elliot L Botvinick; Steven C George; Christopher C W Hughes Journal: Tissue Eng Part A Date: 2016-08 Impact factor: 3.845
Authors: Xi Lou; Meng Zhao; Chengming Fan; Vladimir G Fast; Mani T Valarmathi; Wuqiang Zhu; Jianyi Zhang Journal: Cardiovasc Res Date: 2020-03-01 Impact factor: 10.787
Authors: Xulei Qin; Haodong Chen; Huaxiao Yang; Haodi Wu; Xin Zhao; Huiyuan Wang; Tony Chour; Evgenios Neofytou; Dan Ding; Heike Daldrup-Link; Sarah C Heilshorn; Kai Li; Joseph C Wu Journal: Adv Funct Mater Date: 2017-11-08 Impact factor: 18.808